Merck & Co. has nixed the phase 2 study of a potential Alzheimer’s disease medicine after the drug underwhelmed in an interim analysis, marking another blow for the pharma’s struggling partner ...
Romania has taken a number of steps to upgrade its defenses amid the war in Ukraine just across its border, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results